The WHO Technical Advisory Group reviewed candidate vaccines for Bundibugyo virus disease (BVD) and provided recommendations on prioritization for future development and clinical evaluation
ebola-BDBV
This resource appears in the following Hot Topic page:
The resource is included in the following table:
| Title | Author | Year | Type | Language |
|---|
| WHO Technical Advisory Group on candidate vaccine prioritization (TAG-CVP) for BVD candidate vaccine prioritization (TAG-CVP) meeting report, 31 July 2026 | World Health Organization (WHO) | 2026 | Report | English |
| Frequently asked questions (FAQs) on Bundibugyo Virus Disease vaccines and therapeutics | World Health Organization (WHO), WHO Regional Office for Africa (AFRO) | 2026 | Datasheet | English, French |
| GNN webinar: Updates on existing and pipeline Ebola vaccines | Helen Rees, Reena Doshi, Alejandro Costa, Melanie Marti, Pierre Gsell | 2026 | Webinar | English |
| WHO emergency guidance on the use of licensed Ebola vaccine during Bundibugyo virus disease outbreaks: interim guidance, 31 August 2026 | World Health Organization (WHO) | 2026 | Guidance | English, French |
| WHO emergency guidance on the use of licensed Ebola virus vaccine during Bundibugyo virus disease outbreaks, 28 May 2026 | World Health Organization (WHO) | 2026 | Guidance | English |
| WHO target product profile for Bundibugyo virus disease vaccines | World Health Organization (WHO) | 2026 | Report | English |
| WHO Technical Advisory Group on Candidate Vaccine Prioritization Meeting report, 19 and 25 May 2026 | World Health Organization (WHO) | 2026 | Report | English |
Added by: Reena Doshi
Added on: 2026-06-09 09:54:39
Hits: 705
